These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6941956)

  • 1. Absorption, distribution and excretion of cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kita Y; Yamazaki I; Kondo M; Noji Y; Fugono T
    J Antibiot (Tokyo); 1980 Dec; 33(12):1532-44. PubMed ID: 6941956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kondo M; Kita Y; Noji Y; Takeuchi M; Fugono T
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. V. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin derivates and related compounds.
    Ochiai M; Morimoto A; Miyawaki T; Matsushita Y; Okada T; Natsugari H; Kida M
    J Antibiot (Tokyo); 1981 Feb; 34(2):171-85. PubMed ID: 6271716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of cefsulodin, an antipseudomonal cephalosporin, in mice, rats and dogs.
    Tsuchiya K; Nagatomo H; Kondo M; Kita Y; Fugono T
    J Antibiot (Tokyo); 1978 Jun; 31(6):593-7. PubMed ID: 681241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.
    Tanayama S; Yoshida K; Adachi K; Kondo T
    Antimicrob Agents Chemother; 1980 Oct; 18(4):511-8. PubMed ID: 6934706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Aug; 34(8):1055-63. PubMed ID: 6274837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on beta-lactam antibiotics for medicinal purposes. XXI. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (1)].
    Saikawa I; Tai M; Sugimoto Y; Imaizumi H; Takeda K; Sadaki H
    Yakugaku Zasshi; 1986 Jun; 106(6):466-77. PubMed ID: 3761157
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light and electron microscopy of the morphological response of Escherichia coli and Serratia marcescens to cefmenoxime (SCE-1365), a new broad-spectrum cephalosporin.
    Nakao M; Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Aug; 34(8):1046-54. PubMed ID: 6274836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
    Kita Y; Fugono T; Imada A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
    Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
    Jpn J Antibiot; 1986 Apr; 39(4):979-90. PubMed ID: 3761551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.
    Kita Y; Yamazaki T; Imada A
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2481-6. PubMed ID: 1489192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deacetoxy-7-(alpha-amino-1-cyclohexenylacetamido) cephalosporanic acid (SCE-100), a new semisynthetic cephalosporin. III. Comparative studies on absorption, distribution and excretion of SCE-100 and cephalexin (CEX) in laboratory animals.
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1976 May; 29(5):571-8. PubMed ID: 956046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. VI. Alternative syntheses of 7 beta-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]cephalosporin derivatives.
    Ochiai M; Morimoto A; Miyawaki T
    J Antibiot (Tokyo); 1981 Feb; 34(2):186-92. PubMed ID: 6271717
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Noguchi M; Yamauchi H; Shimizu H
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.